In the BioHarmony Drug Report Database

"Preview" Icon

Meglumine

Renovue (meglumine) is a small molecule pharmaceutical. Meglumine was first approved as Renovue on 1982-01-01. It is used to treat aids-related opportunistic infections, cutaneous leishmaniasis, and visceral leishmaniasis in the USA.

 

Trade Name

 

Renovue
 

Common Name

 

meglumine
 

ChEMBL ID

 

CHEMBL1200570
 

Indication

 

aids-related opportunistic infections, cutaneous leishmaniasis, visceral leishmaniasis
 

Drug Class

 

Image (chem structure or protein)

Meglumine structure rendering